On October 3, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with platinum-doublet chemotherapy as neoadjuvant treatment, followed by single-agent nivolumab […]
Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Bruce D. Curtis/Marianne L. Curtis Recipient Title Co-owner(s) Living Foods LLC 1456 Marilee Dr.Lawrence, KS […]
How Generic Advances Public Health by Improving Access to Affordable Medication Access to affordable medicines remains a significant public health priority for FDA. The agency regularly […]
What is FDA posting? The following reports list potential signals of serious risks/new safety information that were identified using the FAERS database during the indicated quarter. […]
The drug product(s) included in any of the potential signals of serious risks/new safety information listed below may also include the generic version of the drug […]
Report issues to FDA Visit FDA’s statement on tirzepatide Understanding unapproved versions of these drugs FDA is aware that some patients and health care professionals may […]
[10/02/2024] The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has […]
Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Ryuji Hirooka Recipient Title President and Director World Nutrition, Inc. 9449 N 90th Street Ste […]
[10-2-2024] FDA continues to advise consumers not to purchase or use Body Shape Weight Loss System, a product promoted and sold for weight loss. This product […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.